The HABP2 G534E polymorphism does not increase nonmedullary thyroid cancer risk in hispanics

Mabel E. Boh�rquez, Ana P. Estrada, Jacob Stultz, Ruta Sahasrabudhe, John Williamson, Paul Lott, Carlos S. Duque, Jorge Donado, Gilbert Mateus, Fernando Bola�os, Alejandro V�lez, Magdalena Echeverry, Luis Carvajal-Carmona

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Familial nonmedullary thyroid cancer (NMTC) has not been clearly linked to causal germline variants, despite the large role that genetic factors play in risk. Recently, HABP2 G534E (rs7080536A) has been implicated as a causal variant in NMTC. We have previously shown that the HABP2 G534E variant is not associated with TC risk in patients from the British Isles. Hispanics are the largest and the youngest minority in the United States and NMTC is now the second most common malignancy in women from this population. In order to determine if the HABP2 G534E variant played a role in NMTC risk among Hispanic populations, we analyzed 281 cases and 1105 population-matched controls from a multicenter study in Colombia, evaluating the association through logistic regression. We found that the HABP2 G534E variant was not significantly associated with NMTC risk (P = 0.843) in this Hispanic group. We also stratified available clinical data by multiple available clinicopathological variables and further analyzed the effect of HABP2 on NMTC presentation. However, we failed to detect associations between HABP2 G534E and NMTC risk, regardless of disease presentation (P ≥ 0.273 for all cases). Therefore, without any significant associations between the HABP2 G534E variant and NMTC risk, we conclude that the variant is not causal of NMTC in this Hispanic population.

Original languageEnglish (US)
Pages (from-to)123-127
Number of pages5
JournalEndocrine Connections
Volume5
Issue number3
DOIs
StatePublished - May 1 2016

Fingerprint

Thyroid Neoplasms
Hispanic Americans
Population
Population Control
Colombia
Multicenter Studies
Logistic Models
Neoplasms

Keywords

  • G534E
  • HABP2
  • Hispanics
  • Thyroid cancer

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Boh�rquez, M. E., Estrada, A. P., Stultz, J., Sahasrabudhe, R., Williamson, J., Lott, P., ... Carvajal-Carmona, L. (2016). The HABP2 G534E polymorphism does not increase nonmedullary thyroid cancer risk in hispanics. Endocrine Connections, 5(3), 123-127. https://doi.org/10.1530/EC-16-0017

The HABP2 G534E polymorphism does not increase nonmedullary thyroid cancer risk in hispanics. / Boh�rquez, Mabel E.; Estrada, Ana P.; Stultz, Jacob; Sahasrabudhe, Ruta; Williamson, John; Lott, Paul; Duque, Carlos S.; Donado, Jorge; Mateus, Gilbert; Bola�os, Fernando; V�lez, Alejandro; Echeverry, Magdalena; Carvajal-Carmona, Luis.

In: Endocrine Connections, Vol. 5, No. 3, 01.05.2016, p. 123-127.

Research output: Contribution to journalArticle

Boh�rquez, ME, Estrada, AP, Stultz, J, Sahasrabudhe, R, Williamson, J, Lott, P, Duque, CS, Donado, J, Mateus, G, Bola�os, F, V�lez, A, Echeverry, M & Carvajal-Carmona, L 2016, 'The HABP2 G534E polymorphism does not increase nonmedullary thyroid cancer risk in hispanics', Endocrine Connections, vol. 5, no. 3, pp. 123-127. https://doi.org/10.1530/EC-16-0017
Boh�rquez ME, Estrada AP, Stultz J, Sahasrabudhe R, Williamson J, Lott P et al. The HABP2 G534E polymorphism does not increase nonmedullary thyroid cancer risk in hispanics. Endocrine Connections. 2016 May 1;5(3):123-127. https://doi.org/10.1530/EC-16-0017
Boh�rquez, Mabel E. ; Estrada, Ana P. ; Stultz, Jacob ; Sahasrabudhe, Ruta ; Williamson, John ; Lott, Paul ; Duque, Carlos S. ; Donado, Jorge ; Mateus, Gilbert ; Bola�os, Fernando ; V�lez, Alejandro ; Echeverry, Magdalena ; Carvajal-Carmona, Luis. / The HABP2 G534E polymorphism does not increase nonmedullary thyroid cancer risk in hispanics. In: Endocrine Connections. 2016 ; Vol. 5, No. 3. pp. 123-127.
@article{820268fd7a7c43168bc552580a0a3f7d,
title = "The HABP2 G534E polymorphism does not increase nonmedullary thyroid cancer risk in hispanics",
abstract = "Familial nonmedullary thyroid cancer (NMTC) has not been clearly linked to causal germline variants, despite the large role that genetic factors play in risk. Recently, HABP2 G534E (rs7080536A) has been implicated as a causal variant in NMTC. We have previously shown that the HABP2 G534E variant is not associated with TC risk in patients from the British Isles. Hispanics are the largest and the youngest minority in the United States and NMTC is now the second most common malignancy in women from this population. In order to determine if the HABP2 G534E variant played a role in NMTC risk among Hispanic populations, we analyzed 281 cases and 1105 population-matched controls from a multicenter study in Colombia, evaluating the association through logistic regression. We found that the HABP2 G534E variant was not significantly associated with NMTC risk (P = 0.843) in this Hispanic group. We also stratified available clinical data by multiple available clinicopathological variables and further analyzed the effect of HABP2 on NMTC presentation. However, we failed to detect associations between HABP2 G534E and NMTC risk, regardless of disease presentation (P ≥ 0.273 for all cases). Therefore, without any significant associations between the HABP2 G534E variant and NMTC risk, we conclude that the variant is not causal of NMTC in this Hispanic population.",
keywords = "G534E, HABP2, Hispanics, Thyroid cancer",
author = "Boh{\"i}¿½rquez, {Mabel E.} and Estrada, {Ana P.} and Jacob Stultz and Ruta Sahasrabudhe and John Williamson and Paul Lott and Duque, {Carlos S.} and Jorge Donado and Gilbert Mateus and Fernando Bola{\"i}¿½os and Alejandro V{\"i}¿½lez and Magdalena Echeverry and Luis Carvajal-Carmona",
year = "2016",
month = "5",
day = "1",
doi = "10.1530/EC-16-0017",
language = "English (US)",
volume = "5",
pages = "123--127",
journal = "Endocrine Connections",
issn = "2049-3614",
publisher = "BioScientifica Ltd.",
number = "3",

}

TY - JOUR

T1 - The HABP2 G534E polymorphism does not increase nonmedullary thyroid cancer risk in hispanics

AU - Boh�rquez, Mabel E.

AU - Estrada, Ana P.

AU - Stultz, Jacob

AU - Sahasrabudhe, Ruta

AU - Williamson, John

AU - Lott, Paul

AU - Duque, Carlos S.

AU - Donado, Jorge

AU - Mateus, Gilbert

AU - Bola�os, Fernando

AU - V�lez, Alejandro

AU - Echeverry, Magdalena

AU - Carvajal-Carmona, Luis

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Familial nonmedullary thyroid cancer (NMTC) has not been clearly linked to causal germline variants, despite the large role that genetic factors play in risk. Recently, HABP2 G534E (rs7080536A) has been implicated as a causal variant in NMTC. We have previously shown that the HABP2 G534E variant is not associated with TC risk in patients from the British Isles. Hispanics are the largest and the youngest minority in the United States and NMTC is now the second most common malignancy in women from this population. In order to determine if the HABP2 G534E variant played a role in NMTC risk among Hispanic populations, we analyzed 281 cases and 1105 population-matched controls from a multicenter study in Colombia, evaluating the association through logistic regression. We found that the HABP2 G534E variant was not significantly associated with NMTC risk (P = 0.843) in this Hispanic group. We also stratified available clinical data by multiple available clinicopathological variables and further analyzed the effect of HABP2 on NMTC presentation. However, we failed to detect associations between HABP2 G534E and NMTC risk, regardless of disease presentation (P ≥ 0.273 for all cases). Therefore, without any significant associations between the HABP2 G534E variant and NMTC risk, we conclude that the variant is not causal of NMTC in this Hispanic population.

AB - Familial nonmedullary thyroid cancer (NMTC) has not been clearly linked to causal germline variants, despite the large role that genetic factors play in risk. Recently, HABP2 G534E (rs7080536A) has been implicated as a causal variant in NMTC. We have previously shown that the HABP2 G534E variant is not associated with TC risk in patients from the British Isles. Hispanics are the largest and the youngest minority in the United States and NMTC is now the second most common malignancy in women from this population. In order to determine if the HABP2 G534E variant played a role in NMTC risk among Hispanic populations, we analyzed 281 cases and 1105 population-matched controls from a multicenter study in Colombia, evaluating the association through logistic regression. We found that the HABP2 G534E variant was not significantly associated with NMTC risk (P = 0.843) in this Hispanic group. We also stratified available clinical data by multiple available clinicopathological variables and further analyzed the effect of HABP2 on NMTC presentation. However, we failed to detect associations between HABP2 G534E and NMTC risk, regardless of disease presentation (P ≥ 0.273 for all cases). Therefore, without any significant associations between the HABP2 G534E variant and NMTC risk, we conclude that the variant is not causal of NMTC in this Hispanic population.

KW - G534E

KW - HABP2

KW - Hispanics

KW - Thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=84983374872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983374872&partnerID=8YFLogxK

U2 - 10.1530/EC-16-0017

DO - 10.1530/EC-16-0017

M3 - Article

AN - SCOPUS:84983374872

VL - 5

SP - 123

EP - 127

JO - Endocrine Connections

JF - Endocrine Connections

SN - 2049-3614

IS - 3

ER -